Morison makes brand change

Sri Lanka’s leading pharmaceutical manufacturing company Morison Plc partnered Brand Finance and Landor to capture its new vision for the future by codifying the DNA of its organisation and signifying a rejuvenated course of direction. 

For over seven decades J.L. Morison Son & Jones has manufactured and marketed best-in-class products, establishing itself as a reputed and trusted healthcare solutions provider in Sri Lanka. Following the acquisition of the company by Hemas Holdings, and in keeping with its vision to chart a new and bold course which includes a focus on exports, the company changed its name to Morison Plc to be more succinct and relevant to the times. In this context, in order to enable the company to better define its brand to all stakeholders they turned to Brand Finance and Landor to do so. 

Managing Director Trihan Perera said: “The company is continuing to build on a range of safe and efficacious products and solutions that protect and enhance the wellbeing of consumers. To do so, it intends to launch a state-of-the-art pharmaceutical research and manufacturing facility set to commence operations in March 2019.” Brand Finance Lanka Managing Director Ruchi Gunewardene added: “Morison has introduced a new way of thinking to the organisation—a mindset that boldly challenges the status quo. While it will continue to build on the company’s values and vision, the brand intends to capture and reinforce the dynamism and innovation of a company that is navigating towards broader horizons, coupled with a desire to add value to the lives of consumers via cutting-edge technology. 

“It is critical to define the brand in a way which would support the vision of the company and not look at it as a pure design challenge, which is what we wanted to do. We are happy that it met the needs of the business,” Gunewardene stated.